Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Neoplasm Metastasis 1 Castration-resistant Prostate Cancer 1

Interventions

Leucovorin 22 Fluorouracil 22 Paclitaxel 21 Gemcitabine 21 Docetaxel 21 Capecitabine 21 Irinotecan 16 Carboplatin 15 Radiosurgery 14 Oxaliplatin 13 Cisplatin 13 Bevacizumab 13 Zoledronic Acid 12 pembrolizumab 11 Radiotherapy 11 Fulvestrant 11 palbociclib 9 Pemetrexed 9 Drug Therapy 9 130-nm albumin-bound paclitaxel 9 Surgical Procedures, Operative 7 Letrozole 7 Ibandronic Acid 7 abemaciclib 6 Trastuzumab 6 Prednisone 6 Vinorelbine 5 Folfox protocol 5 Floxuridine 5 Doxorubicin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasm Metastasis × Metastasectomy × Clear all

NCT05352178 2024-07-03

SPARKLE

Universitaire Ziekenhuizen KU Leuven

Phase 3 Recruiting

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡